Free Trial

Acurx Pharmaceuticals (ACXP) Stock Price, News & Analysis

0.00 (0.00%)
(As of 03:59 PM ET)
Today's Range
50-Day Range
52-Week Range
40,898 shs
Average Volume
137,520 shs
Market Capitalization
$39.76 million
P/E Ratio
Dividend Yield
Price Target

Acurx Pharmaceuticals MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
378.1% Upside
$12.00 Price Target
Short Interest
4.43% of Float Sold Short
Dividend Strength
News Sentiment
0.24mentions of Acurx Pharmaceuticals in the last 14 days
Based on 3 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($1.28) to ($2.32) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.97 out of 5 stars

Medical Sector

699th out of 931 stocks

Pharmaceutical Preparations Industry

328th out of 433 stocks

ACXP stock logo

About Acurx Pharmaceuticals Stock (NASDAQ:ACXP)

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

ACXP Stock Price History

ACXP Stock News Headlines

Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
Acurx Pharmaceuticals Inc Ordinary Shares
Q4 2023 Acurx Pharmaceuticals Inc Earnings Call
See More Headlines
Receive ACXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
1 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
$0.34 per share


Free Float
Market Cap
$38.97 million
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

ACXP Stock Analysis - Frequently Asked Questions

Should I buy or sell Acurx Pharmaceuticals stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Acurx Pharmaceuticals in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ACXP shares.
View ACXP analyst ratings
or view top-rated stocks.

What is Acurx Pharmaceuticals' stock price target for 2024?

1 brokers have issued 1-year price targets for Acurx Pharmaceuticals' stock. Their ACXP share price targets range from $12.00 to $12.00. On average, they expect the company's stock price to reach $12.00 in the next year. This suggests a possible upside of 378.1% from the stock's current price.
View analysts price targets for ACXP
or view top-rated stocks among Wall Street analysts.

How have ACXP shares performed in 2024?

Acurx Pharmaceuticals' stock was trading at $3.83 at the start of the year. Since then, ACXP stock has decreased by 34.5% and is now trading at $2.51.
View the best growth stocks for 2024 here

When is Acurx Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our ACXP earnings forecast

How were Acurx Pharmaceuticals' earnings last quarter?

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) issued its quarterly earnings data on Friday, March, 15th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.12.

When did Acurx Pharmaceuticals IPO?

Acurx Pharmaceuticals (ACXP) raised $15 million in an initial public offering on Friday, June 25th 2021. The company issued 2,500,000 shares at a price of $5.00-$7.00 per share. Alexander Capital, L.P. and Network 1 Financial Securities acted as the underwriters for the IPO.

Who are Acurx Pharmaceuticals' major shareholders?

Acurx Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional shareholders include Prospect Financial Services LLC (1.73%), NBC Securities Inc. (0.09%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Carl Sailer, David P Luci and Robert J Deluccia.
View institutional ownership trends

How do I buy shares of Acurx Pharmaceuticals?

Shares of ACXP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ACXP) was last updated on 5/28/2024 by Staff

From Our Partners